CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses

被引:69
|
作者
Mei, Dongdong [1 ]
Luo, Yan [1 ]
Wang, Yan [2 ]
Gong, Jingshan [1 ]
机构
[1] Jinan Univ, Shenzhen Peoples Hosp, Dept Radiol, Clin Med Coll 2, Shenzhen 518020, Guangdong, Peoples R China
[2] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 185 Berry St,Suite 350, San Francisco, CA 94107 USA
关键词
Lung adenocarcinoma; Computed tomography; Radiomics; Epidermal growth factor receptor; GROWTH-FACTOR-RECEPTOR; EXON-21; MUTATIONS; CANCER PATIENTS; GEFITINIB; SURVIVAL; IMAGES;
D O I
10.1186/s40644-018-0184-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo investigate whether radiomic features can be surrogate biomarkers for epidermal growth factor receptor (EGFR) mutation statuses.Materials and methodsTwo hundred ninety six consecutive patients, who underwent CT examinations before operation within 3months and had EGFR mutations tested, were enrolled in this retrospective study. CT texture features were extracted using an open-source software with whole volume segmentation. The association between CT texture features and EGFR mutation statuses were analyzed.ResultsIn the 296 patients, there were 151 patients with EGFR mutations (51%). Logistic analysis identified that lower age (Odds Ratio[OR]: 0.968,95% confidence interval [CI]:0.946 similar to 0.990, p=0.005) and a radiomic feature named GreyLevelNonuniformityNormalized (OR: 0.012, 95% CI:0.000 similar to 0.352, p=0.01) were predictors for exon 19 mutation; higher age (OR: 1.027, 95%CI:1.003 similar to 1.052,p=0.025), female sex (OR: 2.189, 95%CI:1.264 similar to 3.791, p=0.005) and a radiomic feature named Maximum2DDiameterColumn (OR: 0.968, 95%CI:0.946 similar to 0.990], p=0.005) for exon 21 mutation; and female sex (OR: 1.883,95%CI:1.064 similar to 3.329, p=0.030), non-smoking status (OR: 2.070, 95%CI:1.090 similar to 3.929, p=0.026) and a radiomic feature termed SizeZone NonUniformityNormalized (OR: 0.010, 95% CI:0.0001 similar to 0.852, p=0.042) for EGFR mutations. Areas under the curve (AUCs) of combination with clinical and radiomic features to predict exon 19 mutation, exon 21 mutation and EGFR mutations were 0.655, 0.675 and 0.664, respectively.ConclusionSeveral radiomic features are associated with EGFR mutation statuses of lung adenocarcinoma. Combination with clinical files, moderate diagnostic performance can be obtained to predict EGFR mutation status of lung adenocarcinoma. Radiomic features might harbor potential surrogate biomarkers for identification of EGRF mutation statuses.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Analysis of EGFR Mutation Status in CSF and Blood in Lung Adenocarcinoma Patients with EGFR Mutation and CNS Metastasis
    Sen, Y.
    Tang, H.
    Wu, Y.
    He, Z.
    Li, S.
    Wang, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1910 - S1911
  • [22] Relationship between EGFR gene mutation and serum tumor biomarkers in advanced lung adenocarcinoma
    Feng, Yuan
    Zhou, Jihong
    Chen, Sining
    Jiang, Ying
    Zhou, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (01): : 250 - 255
  • [23] Temporal Stability and Prognostic Power of Radiomic Features for Survival Analysis in Lung Adenocarcinoma
    Adiraju, Rama Vasantha
    Elias, Susan
    TRAITEMENT DU SIGNAL, 2023, 40 (06) : 2599 - 2611
  • [24] EGFR Mutation Specific Antibodies Can Detect the Majority of EGFR TKI Sensitizing Mutations in Adenocarcinoma of the Lung
    Solomides, C. C.
    Draganova-Tacheva, R.
    Bibbo, M.
    Ren, S.
    Shi, Y.
    Palazzo, I. E.
    Birbe, R.
    O'Neill, R.
    Peiper, S. C.
    Wang, Z-X
    LABORATORY INVESTIGATION, 2014, 94 : 495A - 495A
  • [25] EGFR Mutation Specific Antibodies Can Detect the Majority of EGFR TKI Sensitizing Mutations in Adenocarcinoma of the Lung
    Solomides, C. C.
    Draganova-Tacheva, R.
    Bibbo, M.
    Ren, S.
    Shi, Y.
    Palazzo, I. E.
    Birbe, R.
    O'Neill, R.
    Peiper, S. C.
    Wang, Z-X
    MODERN PATHOLOGY, 2014, 27 : 495A - 495A
  • [26] EGFR and KRas Mutation Analysis in Lung Adenocarcinoma: Adequacy of Cytology Samples
    Heymann, J. J.
    Saab, J.
    Zachariah, J.
    Hoda, R. S.
    LABORATORY INVESTIGATION, 2013, 93 : 92A - 92A
  • [27] EGFR and KRas Mutation Analysis in Lung Adenocarcinoma: Adequacy of Cytology Samples
    Heymann, J. J.
    Saab, J.
    Zachariah, J.
    Hoda, R. S.
    MODERN PATHOLOGY, 2013, 26 : 92A - 92A
  • [28] Analysis of EGFR mutation status in blood and CSF in lung adenocarcinoma patients with EGFR mutation and CNS metastasis by ddPCR
    Sen, Y.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2017, 28 : 183 - 183
  • [29] A predictive model of computed tomography and clinical features of EGFR gene mutation in lung adenocarcinoma
    Yao, Youjian
    Zhang, Nengde
    Lu, Caiwei
    Liu, Lianhua
    Fu, Yu
    Gui, Mei
    SCIENCE PROGRESS, 2024, 107 (04)
  • [30] Clinical and Genetic Features in Lung Adenocarcinoma Without EGFR Mutation and ALK Rearrangement in Taiwan
    Shiao, T.
    Chiang, C.
    Luo, Y.
    Chao, H.
    Huang, H.
    Chiu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2252 - S2253